The Valley Desk

NCT07222137 · Interventional trial

A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults

Overall registry status Recruiting

Phase 3

Conditions Diabetes Mellitus, Type 1

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov